Key result
Vitamin K antagonist therapy knowledge among newly treated patients was insufficient, with a mean overall score of 5.78 out of 20.
Why the study?
The study was conducted to assess the level of Vitamin K antagonist therapy knowledge among newly treated patients.
What is the level of knowledge regarding Vitamin K antagonist therapy among newly treated patients?
Cross-Sectional (n=55)
No
What is the level of knowledge regarding Vitamin K antagonist therapy among newly treated patients?
Newly treated patients on Vitamin K antagonists demonstrate insufficient knowledge about their therapy, emphasizing the need for better patient education to ensure adherence and safety.
Insufficient VKA knowledge in new patients signals education gaps; cross-sectional data leaves open effects on adherence or outcomes.
OBJECTIVE: The objective of this study was to assess the level of Vitamin K antagonist (VKA) therapy knowledge among VKA newly treated patients. METHODS: Questionnaire-based interviews were administered in a university hospital to VKA newly treated patients covering both cognitive (i.e. indication, route of administration, treatment monitoring and side effects) and know-how (i.e. safety precautions, what affects anticoagulant therapy and the management of overdose signs) aspects of therapy knowledge. KEY FINDINGS: A total of 55 patients were included. The mean overall score of patients' knowledge was 5.78 (SD = 3.425) out of 20. The mean scores of cognitive and practical knowledge were 3.8 (2.26) and 1.98 (1.78) out of 10, respectively. Factors associated with an insufficient level of VKA therapy knowledge included low level of education, lack of access to therapy information and continuous access to this information. CONCLUSIONS: Knowledge about VKA therapy among newly treated patients is insufficient. Patient's medication knowledge should be improved to ensure better adherence.
No takes yet. Share an insight, caveat, or question.
Jeddou et al. (2021) conducted a cross-sectional in Newly treated with Vitamin K antagonists (n=55). Vitamin K antagonist (VKA) therapy was evaluated on Level of VKA therapy knowledge (overall score out of 20). Vitamin K antagonist therapy knowledge among newly treated patients was insufficient, with a mean overall score of 5.78 out of 20.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: